Using Robinhood stock tokens as collateral to borrow stablecoins sounds like stitching two worlds together, but no one has explained where the seams are. In the markets Morpho just launched, the liquidation thresholds for NVDA and SPCX are both 62.5%, while SPY gets 77%; the borrowed asset is USDG. The numbers make the risk appetite clear: index tokens let you borrow more, while individual stock tokens require a larger buffer.
The problem is that users are not putting up shares of Nvidia as collateral; they’re putting up tokenized claims issued by Robinhood. Three layers separate these tokens from the actual shares: the issuer, the custodian, and the on-chain contract. When liquidation is triggered, Morpho sells the on-chain token, not shares on the New York Stock Exchange. These two markets operate independently, and their prices stay aligned through arbitrage and trust—not a shared ledger. A 62.5% threshold looks conservative, but if prices gap down, whether on-chain liquidity can absorb the selling is another question.
People have been talking for a long time about bringing RWAs permanently on-chain. This is a concrete step in that direction: stock tokens have moved from “hold only” to “use as collateral to earn yield.” But a lending market provides an entry point for leverage, not an upgrade in ownership. If retail investors borrow stablecoins and use them to buy crypto, they’re stacking two layers of risk, while the underlying asset remains the same tokenized claim.
I see this as infrastructure testing its boundaries, not the final destination for putting stocks on-chain. No matter how precisely the liquidation thresholds are set, they can’t resolve who backstops the price gap between the token and the stock. Do you think markets like this should be governed by the risk controls used for crypto assets, or by securities regulations?$NVDA #RWA #DeFi
$NVDB $MSFTB #Stablecoin
The problem is that users are not putting up shares of Nvidia as collateral; they’re putting up tokenized claims issued by Robinhood. Three layers separate these tokens from the actual shares: the issuer, the custodian, and the on-chain contract. When liquidation is triggered, Morpho sells the on-chain token, not shares on the New York Stock Exchange. These two markets operate independently, and their prices stay aligned through arbitrage and trust—not a shared ledger. A 62.5% threshold looks conservative, but if prices gap down, whether on-chain liquidity can absorb the selling is another question.
People have been talking for a long time about bringing RWAs permanently on-chain. This is a concrete step in that direction: stock tokens have moved from “hold only” to “use as collateral to earn yield.” But a lending market provides an entry point for leverage, not an upgrade in ownership. If retail investors borrow stablecoins and use them to buy crypto, they’re stacking two layers of risk, while the underlying asset remains the same tokenized claim.
I see this as infrastructure testing its boundaries, not the final destination for putting stocks on-chain. No matter how precisely the liquidation thresholds are set, they can’t resolve who backstops the price gap between the token and the stock. Do you think markets like this should be governed by the risk controls used for crypto assets, or by securities regulations?$NVDA #RWA #DeFi
$NVDB $MSFTB #Stablecoin